The European Commission approves the first gene editing treatment with CRISPR | Science
The European Commission has authorized the first treatment that uses the revolutionary CRISPR technique to edit human DNA. The therapy, called Casgevy, is effective against beta thalassemia and sickle cell anemia, two potentially fatal blood diseases. More than 8,000 patients in Europe qualify to receive this treatment, according to the American company Vertex Pharmaceuticals, developer … Read more